Lucida Medical

Lucida Medical, an AI-powered diagnostic startup based in Cambridge, has successfully secured £8.7 million in a recent funding round. This investment is set to bolster its efforts in developing and deploying AI solutions for prostate cancer diagnosis from MRI scans, aiming to support clinicians and meet rising demands within the NHS.

Summary of transaction details:

• Value: £8.7 million
• Sector: Healthcare & Biotech, DeepTech & AI
• Advisor: None mentioned
• Key Entities: Lucida Medical (Target), IW Capital (Lead Investor), Macmillan Cancer Support, XTX Ventures (Investors)
• Location: Cambridge, UK

Note: This funding round underscores the growing investor confidence in AI-driven healthcare solutions, particularly those addressing critical bottlenecks in diagnostics and improving patient outcomes. The participation of Macmillan Cancer Support highlights the societal impact and potential of Lucida Medical's technology in revolutionising cancer care.